IP Library › Assignment 017149/0949
Patent Assignment
Reel/Frame 017149/0949

Merger

Recorded: 2005-12-28 Pages: 14
Assignor
Assignee
DAINIPPON SUMITOMO PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA-FU 541-8524, JAPAN
Covered Properties (3)
Hla-A24-Restricted Cancer Antigen Peptides
Patent: 7,420,034 →
Application: 10/517,600 →
Publication: US 2007/0082860
WT1 Substitution Pepides
Patent: 7,378,384 →
Application: 10/528,360 →
Publication: US 2006/0205667
Dimerized peptide
Application: 10/541,821 →
Publication: US 2006/0217297
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 13, 2004
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 016619/0189 →
Assignment of Assignor's Interest Mar 18, 2005
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO; SAMIZO, FUMIO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 016836/0856 →
Assignment of Assignor's Interest Jul 11, 2005
From: SUGIYAMA, HARUO; TAKASU, HIDEO; SAMIZO, FUMIO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 017576/0994 →
Assignment of Assignor's Interest Aug 29, 2006
From: SUGIYAMA, HARUO
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 018192/0210 →
Corrected Form Pto-1595 Correct Assignees #2 and # Dec 13, 2006
From: SUGIYAMA, HARUO; GOTOH, MASASHI; TAKASU, HIDEO; SAMIZO, FUMIO
To: SUGIYAMA, HARUO; CHUGAI SEIYAKU KABUSHIKI KAISHA; SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 018704/0620 →
Change of Name Oct 10, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033969/0194 →
Assignment of Assignor's Interest Apr 25, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 038364/0495 →
Assignment of Assignor's Interest Aug 16, 2017
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 043305/0542 →